145 related articles for article (PubMed ID: 35985497)
1. Absence of NC14A Domain of COLXVII/BP180 in Mice Results in IL-17‒Associated Skin Inflammation.
Lindgren O; Le Menn G; Tuusa J; Chen ZJ; Tasanen K; Kokkonen N
J Invest Dermatol; 2023 Jan; 143(1):48-56.e7. PubMed ID: 35985497
[TBL] [Abstract][Full Text] [Related]
2. Deletion of the major bullous pemphigoid epitope region of collagen XVII induces blistering, autoimmunization, and itching in mice.
Hurskainen T; Kokkonen N; Sormunen R; Jackow J; Löffek S; Soininen R; Franzke CW; Bruckner-Tuderman L; Tasanen K
J Invest Dermatol; 2015 May; 135(5):1303-1310. PubMed ID: 25310407
[TBL] [Abstract][Full Text] [Related]
3. Subepidermal blistering induced by human autoantibodies to BP180 requires innate immune players in a humanized bullous pemphigoid mouse model.
Liu Z; Sui W; Zhao M; Li Z; Li N; Thresher R; Giudice GJ; Fairley JA; Sitaru C; Zillikens D; Ning G; Marinkovich MP; Diaz LA
J Autoimmun; 2008 Dec; 31(4):331-8. PubMed ID: 18922680
[TBL] [Abstract][Full Text] [Related]
4. Autoantibodies Against the Immunodominant Bullous Pemphigoid Epitopes Are Rare in Patients With Dermatitis Herpetiformis and Coeliac Disease.
Nätynki A; Tuusa J; Hervonen K; Kaukinen K; Lindgren O; Huilaja L; Kokkonen N; Salmi T; Tasanen K
Front Immunol; 2020; 11():575805. PubMed ID: 33072118
[TBL] [Abstract][Full Text] [Related]
5. A Case of Anti-BP180-type Mucous Membrane Pemphigoid with IgG and IgA Autoantibodies Showing Distinct Reactivities.
Minakawa S; Matsuzaki Y; Hashimoto T; Ishii N; Nishie W; Nakazawa M; Sawamura D
Acta Dermatovenerol Croat; 2022 Jul; 30(1):54-56. PubMed ID: 36153720
[TBL] [Abstract][Full Text] [Related]
6. Autoantibodies in lichen planus pemphigoides react with a novel epitope within the C-terminal NC16A domain of BP180.
Zillikens D; Caux F; Mascaro JM; Wesselmann U; Schmidt E; Prost C; Callen JP; Bröcker EB; Diaz LA; Giudice GJ
J Invest Dermatol; 1999 Jul; 113(1):117-21. PubMed ID: 10417629
[TBL] [Abstract][Full Text] [Related]
7. Itch, eosinophils, and autoimmunity: a novel murine model of bullous pemphigoid.
Yancey KB
J Invest Dermatol; 2015 May; 135(5):1213-1215. PubMed ID: 25882461
[TBL] [Abstract][Full Text] [Related]
8. Autoantibodies in a subgroup of patients with linear IgA disease react with the NC16A domain of BP1801.
Zillikens D; Herzele K; Georgi M; Schmidt E; Chimanovitch I; Schumann H; Mascaro JM; Diaz LA; Bruckner-Tuderman L; Bröcker EB; Giudice GJ
J Invest Dermatol; 1999 Dec; 113(6):947-53. PubMed ID: 10594735
[TBL] [Abstract][Full Text] [Related]
9. Normal human skin is superior to monkey oesophagus substrate for detection of circulating BP180-NC16A-specific IgG antibodies in bullous pemphigoid.
Emtenani S; Yuan H; Lin C; Pan M; Hundt JE; Schmidt E; Komorowski L; Stanley JR; Hammers CM
Br J Dermatol; 2019 May; 180(5):1099-1106. PubMed ID: 30315657
[TBL] [Abstract][Full Text] [Related]
10. Fc-binding proteins enhance autoantibody-induced BP180 depletion in pemphigoid.
Iwata H; Kamaguchi M; Ujiie H; Ujiie I; Natsuga K; Nishie W; Shimizu H
J Pathol; 2019 Mar; 247(3):371-380. PubMed ID: 30426510
[TBL] [Abstract][Full Text] [Related]
11. The pathophysiology of bullous pemphigoid.
Kasperkiewicz M; Zillikens D
Clin Rev Allergy Immunol; 2007 Oct; 33(1-2):67-77. PubMed ID: 18094948
[TBL] [Abstract][Full Text] [Related]
12. [New aspects on the pathogenesis of bullous pemphigoid].
Schmidt E; Bröcker EB; Zillikens D
Hautarzt; 2000 Sep; 51(9):637-45. PubMed ID: 11057389
[TBL] [Abstract][Full Text] [Related]
13. Checkpoint Inhibition May Trigger the Rare Variant of Anti-LAD-1 IgG-Positive, Anti-BP180 NC16A IgG-Negative Bullous Pemphigoid.
Sadik CD; Langan EA; Grätz V; Zillikens D; Terheyden P
Front Immunol; 2019; 10():1934. PubMed ID: 31474998
[TBL] [Abstract][Full Text] [Related]
14. Bullous pemphigoid of childhood: autoantibodies target the same epitopes within the NC16A domain of BP180 as autoantibodies in bullous pemphigoid of adulthood.
Chimanovitch I; Hamm H; Georgi M; Kroiss M; Stolz W; Apitz C; Bröcker EB; Zillikens D
Arch Dermatol; 2000 Apr; 136(4):527-32. PubMed ID: 10768652
[TBL] [Abstract][Full Text] [Related]
15. BP180 as the common autoantigen in blistering diseases with different clinical phenotypes.
Zillikens D
Keio J Med; 2002 Mar; 51(1):21-8. PubMed ID: 11951375
[TBL] [Abstract][Full Text] [Related]
16. Characteristics of IgG subclasses and complement deposition in BP230-type bullous pemphigoid.
Zheng M; Ujiie H; Iwata H; Muramatsu K; Yoshimoto N; Ito T; Ujiie I; Shimizu S; Sato-Matsumura KC; Shimizu H
J Eur Acad Dermatol Venereol; 2019 Mar; 33(3):595-600. PubMed ID: 30394605
[TBL] [Abstract][Full Text] [Related]
17. Super-resolution imaging detects BP180 autoantigen in immunoglobulin M pemphigoid.
Hirano Y; Iwata H; Tsujuwaki M; Mai S; Mai Y; Imafuku K; Izumi K; Koga H; Ujiie H
J Dermatol; 2022 Mar; 49(3):374-378. PubMed ID: 34845743
[TBL] [Abstract][Full Text] [Related]
18. Functional characterization of an IgE-class monoclonal antibody specific for the bullous pemphigoid autoantigen, BP180.
Messingham KA; Onoh A; Vanderah EM; Giudice GJ; Fairley JA
Hybridoma (Larchmt); 2012 Apr; 31(2):111-7. PubMed ID: 22509915
[TBL] [Abstract][Full Text] [Related]
19. Immune Reaction to Type XVII Collagen Induces Intramolecular and Intermolecular Epitope Spreading in Experimental Bullous Pemphigoid Models.
Ujiie H; Yoshimoto N; Natsuga K; Muramatsu K; Iwata H; Nishie W; Shimizu H
Front Immunol; 2019; 10():1410. PubMed ID: 31275329
[TBL] [Abstract][Full Text] [Related]
20. IgG autoantibodies from a lichen planus pemphigoides patient recognize the NC16A domain of the bullous pemphigoid antigen 180.
Skaria M; Salomon D; Jaunin F; Friedli A; Saurat JH; Borradori L
Dermatology; 1999; 199(3):253-5. PubMed ID: 10592407
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
